title: Relationship between response to interferon therapy and detection of hepatitis C virus RNA by differential flotation centrifugation.
abstract: Circulating hepatitis C virus (HCV) particles can be fractionated by means of differential flotation centrifugation. It is reported that in the bottom fraction HCV is in the form immune complexes, whereas in the top, it is free of antibodies. We evaluated the significance of circulating complex and free HCV in chronic hepatitis C, and assessed the relationship in terms of the response to interferon (IFN) therapy. We examined sera before, just after, and 1 year after administering IFN to 18 patients with chronic hepatitis C, 10 of whom responded (group CR), and 8 did not (group NR). The amounts of virus were similar between both groups before therapy. After differential flotation centrifugation with 1.063 g/ml of NaCl, the top and bottom fractions were assayed for HCV RNA. Before therapy, HCV RNA was detected in the top fraction in 1 of 10 in group CR, and in 6 of 8 in group NR (P < 0.05, chi-square test). HCV RNA was positive in the bottom fraction of all samples. In a follow-up study of group NR, HCV RNA was detected in the top fraction in 3 of 8 just after IFN therapy, and in 7 of 8 after 1 year. This study suggests that the presence of HCV in the top fraction can predict a poor response to IFN therapy.
authors.affiliation: First Department of Internal Medicine, Okayama University Medical School, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Wato
authors.forename: H
authors.initials: H
authors.lastname: Shimomura
authors.forename: K
authors.initials: K
authors.lastname: Fujio
authors.forename: H
authors.initials: H
authors.lastname: Tsuji
authors.forename: J
authors.initials: J
authors.lastname: Kondo
authors.forename: S
authors.initials: S
authors.lastname: Fujioka
authors.forename: Y
authors.initials: Y
authors.lastname: Ishii
authors.forename: H
authors.initials: H
authors.lastname: Hada
authors.forename: T
authors.initials: T
authors.lastname: Tsuji
mesh_terms: D000328:Adult; D000368:Aged; D002498:Centrifugation / Q000379:methods*; D002847:Chromatography, Agarose; D002908:Chronic Disease; D005260:Female; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000628:therapy* / Q000821:virology*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000032:analysis*; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D012367:RNA, Viral; D007372:Interferons